Therefore, transfer of p16 cDNA through recombinant replication-defective adenoviral vector to glioma cells markedly inhibited angiogenesis through suppressing vascular endothelial growth factor (VEGF) expression (Harada et al., 1999). The gene discussed is CDKN2A; the disease is central nervous system cancer.